. -The key intermediate (IV) for the synthesis of the title compounds (VII) and (VIII) is conveniently obtained in a selective ring-opening fluorination of epoxide (III) using hydrofluoric acid. Compound (IV) is coupled with nucleosidic bases under Mitsunobu conditions followed by deprotection. The cytosine analogue (VII) shows potent anti-HCV activity. -(LIU, L.